17 hrs ago | The Motley Fool
Biotechs can offer insane returns in a very short time, sometimes overnight doubles or triples.
Ridgewater Equity Offers Fundamental & Technical Coverage of Stocks...
Though, Airline and housing stocks were some of the day's strongest performers, with the NYSEArca Airline Index and the Philadelphia Housing Sector Index advancing by 3.2 percent and 2.7 percent, respectively.
Xenomics' Preliminary Investigation Leads the Company to Believe...
Xenomics' Preliminary Investigation Leads the Company to Believe Sequenom Willfully Manipulated its Down Syndrome Data in its Presentations Xenomics, Inc.
Customer Interaction Solutions
PennyStockChaser.com: Pennystockchaser.com:...
December 16, 2009 Compuware Corporation trading at $7.34 on a volume of 733,116 shares Compuware Publishes New Whitepaper: "Compuware, Gomez and the New Application Dynamic: Managing Application Performance in the Internet Era" Whitepaper Gives Readers Actionable Insight Into Requirements for Optimizing Application Performance in Today's Complex ...
Sequenom, Avanir: Early Volume Plays
Several stocks trading under $10 were poised to move on above-average volume during Wednesday's session.
Clarient, Sequenom: Early Volume Plays
Several stocks trading under $5 were poised to move on above-average volume during Monday's session.
Sequenom Stock Now the Plaything of Rumors
It will be interesting to see what happens to Sequenom 's stock on Monday when the markets open again.
Incyte, Sequenom: Early Volume Plays
Several stocks trading under $10 were poised to move on above-average volume during Monday's session.
Skymark Research Initiates Independent Research Coverage on Sequenom, Inc.
CALGARY, Alberta, Nov. 25, 2009 -- Skymark Research, a leading provider of small- and micro-cap independent investment research, today initiated coverage on Sequenom, Inc.
4-Star Stocks Poised to Pop: Sequenom
Based on the aggregated intelligence of 140,000-plus investors participating in Motley Fool CAPS , the Fool's free investing community, diagnostic-test maker Sequenom has earned a respected four-star ranking .
German biotech Caprotec opens Burlington subsidiary
Caprotec bioanalytics GmbH, a Berlin biotechnology firm, has opened a subsidiary in Burlington.
Sequenom Insider Accused of $366K Stock Sale Before Data Corruption Revealed
Steven Owings , the former vp commercial development at Sequenom , sold 22,598 shares for a total of $365,967, on March 24, 2009, a month before the company revealed that all its data for its T21/SEQureDx Down Syndrome test was corrupted by "employee mishandling," according to a lawsuit filed in California federal court.
On this day, we have begun tracking the following companies as they have shown remarkable correction in recent days, you can access these free reports with a number of other reviews by signing up for your complimentary membership at : http://www.rothmanresearch.com/ Companies been researched today are: Total System Services Inc.
Sequenom names Maier as interim CFO
Genetic analysis test maker Sequenom Inc. has named Paul V. Maier as interim chief financial officer, filling another top position in the wake of multiple senior management firings earlier this fall.
Sequenom announces names Maier as interim CFO
Sequenom Inc . announced that Paul V. Maier has been appointed as the company's interim chief financial officer effective Nov.
WallStSense.com Fundamental & Technical Coverage of TSFG, SQNM, CHRS, MDRX, SIRI and LVLT
Our analysts have issued complimentary analysis on the following six companies: South Financial Group Inc.
ATVI, RMBS, MRVL, SQNM, ERIC, AKAM With Highest Daily Short Volume On NASDAQ Friday
BUYINS.NET, www.buyins.net, has reviewed the NASDAQ Daily Short Volume Report for Friday, October 9th, 2009 and come to the following statistical conclusions.
Ivanhoe Energy (IVAN) - Top Gainers on NASDAQ
Dallas, TX - Sequenom, Inc. jumped up by 10.78% to close at $3.70 on a massive volume of 16.41 million shares after Sequenom yesterday announced that all its data is bogus.
Madness at Sequenom: Interim CEO Gets a Pay Rise; Stock Rises 18%
Sequenom just announced that all its data is bogus. It is under investigation by the SEC, NASDAQ, the U.S. Attorney's Office and the FBI .
Sequenom meets with feds over test debacle
In a regulatory filing made late Monday, Sequenom Inc. /quotes/comstock/15*!sqnm /quotes/nls/sqnm said that its officials have met with representatives of the U.S. Attorney's Office, the Securities and Exchange Commission, and the Federal Bureau of Investigations to discuss its announcement that the clinical data used to back up the validity of its ...
Also on Topix